Cost implications of adverse drug event-related emergency department visits–a multicenter study in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, M.-S. | - |
dc.contributor.author | Lee, J.-Y. | - |
dc.contributor.author | Kang, M.-G. | - |
dc.contributor.author | Jung, J.-W. | - |
dc.contributor.author | Park, H.-K. | - |
dc.contributor.author | Park, H.-K. | - |
dc.contributor.author | Kim, S.-H. | - |
dc.contributor.author | Lee, E.-K. | - |
dc.date.available | 2019-06-26T01:30:26Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 1473-7167 | - |
dc.identifier.issn | 1744-8379 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/26333 | - |
dc.description.abstract | Background: Adverse drug reactions (ADRs) increase health-care resource utilization, including that for emergency department (ED) visits. However, cost analyses of ADRs resulting in ED visits are scarce. Therefore, we aimed to estimate the direct medical costs before and after ADR occurrence and analyzed the cost-driving factors. Methods: The ADR cases were identified by a retrospective review of medical records of patients who visited the ED of three tertiary hospitals in South Korea from July to December 2014. The direct medical cost was estimated by the difference in costs six months before and after the ED visit. A generalized linear model was used to identify the ADR-associated cost-driving factors. Results: The mean cost per ADR increased by 26.1% (±SD = 4.3) during the six-month follow-up compared with that during the six months before the ED visit (p < 0.05). Preventable ADRs accounted for approximately 19.9% of the cost increase among all ADR cases. The regression analysis revealed that ‘ADR-related hospitalization’ was a significant (p < 0.05) factor leading to an increase in the direct medical costs. Conclusion: Drug-related ED visits increase the burden on health insurance systems and patients’ out-of-pocket costs, mostly due to the hospitalization costs. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Taylor and Francis Ltd | - |
dc.title | Cost implications of adverse drug event-related emergency department visits–a multicenter study in South Korea | - |
dc.type | Article | - |
dc.identifier.doi | 10.1080/14737167.2019.1608825 | - |
dc.identifier.bibliographicCitation | Expert Review of Pharmacoeconomics and Outcomes Research, v.20, no.1, pp 139 - 146 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000470408600001 | - |
dc.identifier.scopusid | 2-s2.0-85065434426 | - |
dc.citation.endPage | 146 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 139 | - |
dc.citation.title | Expert Review of Pharmacoeconomics and Outcomes Research | - |
dc.citation.volume | 20 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Adverse drug event | - |
dc.subject.keywordAuthor | direct medical cost | - |
dc.subject.keywordAuthor | emergency department | - |
dc.subject.keywordAuthor | pharmacoepidemiology | - |
dc.subject.keywordPlus | INDUCED LIVER-INJURY | - |
dc.subject.keywordPlus | ECONOMIC BURDEN | - |
dc.subject.keywordPlus | CAUSALITY ASSESSMENT | - |
dc.subject.keywordPlus | INTERNAL-MEDICINE | - |
dc.subject.keywordPlus | HOSPITALIZATIONS | - |
dc.subject.keywordPlus | HOSPITALS | - |
dc.subject.keywordPlus | PREVENTABILITY | - |
dc.subject.keywordPlus | MEDICATIONS | - |
dc.subject.keywordPlus | NATIONWIDE | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Health Policy & Services | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.